Qiagen's Q3 Revenues Climb 6 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Monday that revenues for the third quarter rose 6 percent year over year, with molecular diagnostics sales increasing 9 percent.

For the three months ended Sept. 30, the firm posted $274.3 million in sales, up from $259.7 million in the third quarter of 2009. Wall Street expected revenues of $276.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.